These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 20462038

  • 21. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
    Ciuleanu T, Stelmakh L, Cicenas S, Miliauskas S, Grigorescu AC, Hillenbach C, Johannsdottir HK, Klughammer B, Gonzalez EE.
    Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative study on the methods of Chinese medicine and Western medicine therapeutic evaluation for advanced non-small cell lung cancer].
    Zhang PT, Yu MW, Yang ZY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):702-5. PubMed ID: 20929125
    [Abstract] [Full Text] [Related]

  • 25. [Effect of Chinese medicine comprehensive regimen as the maintenance therapy on time to progression and quality of life of patients with advanced non-small-cell lung cancer].
    Jiang Y, Liu LS, Li CJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1311-6. PubMed ID: 22097195
    [Abstract] [Full Text] [Related]

  • 26. [Regulatory effect of jianpi wenshen recipe in combining with chemotherapy on the blood level of estradiol in patients with lung cancer].
    Li CJ, Liu JX, Liu LS.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):26-9. PubMed ID: 19338148
    [Abstract] [Full Text] [Related]

  • 27. A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).
    Hu X, Han B, Gu A, Zhang Y, Jiao SC, Wang CL, He J, Jia X, Zhang L, Peng J, Wu M, Ying K, Wang J, Ma K, Zhang S, You C, Tan F, Wang Y, Ding L, Sun Y.
    Lung Cancer; 2014 Nov; 86(2):207-12. PubMed ID: 25261231
    [Abstract] [Full Text] [Related]

  • 28. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A, Wagenius G, Rylander H, Brodin O, Holmberg E, Lödén B, Ewers SB, Bergström S, Wichardt-Johansson G, Nilsson K, Ekberg L, Sederholm C, Nyman J.
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [Abstract] [Full Text] [Related]

  • 29. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
    Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ.
    Complement Ther Med; 2014 Dec; 22(6):1010-8. PubMed ID: 25453521
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation on effect of feiji recipe on quality of life of patients with non-small cell lung cancer by adopting international questionnaire of QOL].
    You J, Shi ZM, Han BH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan; 26(1):33-7. PubMed ID: 16466169
    [Abstract] [Full Text] [Related]

  • 31. Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.
    Soria JC, Wu YL, Nakagawa K, Kim SW, Yang JJ, Ahn MJ, Wang J, Yang JC, Lu Y, Atagi S, Ponce S, Lee DH, Liu Y, Yoh K, Zhou JY, Shi X, Webster A, Jiang H, Mok TS.
    Lancet Oncol; 2015 Aug; 16(8):990-8. PubMed ID: 26159065
    [Abstract] [Full Text] [Related]

  • 32. Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients.
    Han Y, Wang H, Xu W, Cao B, Han L, Jia L, Xu Y, Zhang Q, Wang X, Zhang G, Yu M, Yang G.
    Complement Ther Med; 2016 Feb; 24():81-9. PubMed ID: 26860807
    [Abstract] [Full Text] [Related]

  • 33. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
    Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C.
    Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
    [Abstract] [Full Text] [Related]

  • 34. [Effect of oleum fructus brucease injection via bronchial arterial infusion in treating advanced lung cancer].
    Bai ZP, Deng XS.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):838-40. PubMed ID: 21038653
    [Abstract] [Full Text] [Related]

  • 35. [Clinical and experimental study of xiaoshui decoction in the treatment of primary liver cancer caused ascites].
    Wu D, Bao WG, Ding YH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1066-9. PubMed ID: 16398423
    [Abstract] [Full Text] [Related]

  • 36. Gefitinib combined with stereotactic radiosurgery in previously treated patients with advanced non-small cell lung cancer.
    Wang Z, Zhu XX, Wu XH, Li B, Shen TZ, Kong QT, Li J, Liu ZB, Jiang WR, Wang Y, Hou B.
    Am J Clin Oncol; 2014 Apr; 37(2):148-53. PubMed ID: 23211223
    [Abstract] [Full Text] [Related]

  • 37. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
    Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M, Gatzemeier U, FLEX Study Team.
    Lancet; 2009 May 02; 373(9674):1525-31. PubMed ID: 19410716
    [Abstract] [Full Text] [Related]

  • 38. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H, Wang LH, Wang XZ, Lü JM, Ji W, Zhou ZM, Ou GF, Yin WB.
    Zhonghua Zhong Liu Za Zhi; 2009 Feb 02; 31(2):143-7. PubMed ID: 19538894
    [Abstract] [Full Text] [Related]

  • 39. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
    Liao ML, Zhou YZ, Ding JA, Ni GX, Zhao JM, Chen WH, Han BH, Shen J, Bai H, Chen ZW, Ji H, Wang HM, Zhou Z.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):962-6. PubMed ID: 12899797
    [Abstract] [Full Text] [Related]

  • 40. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
    Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J.
    Lung Cancer; 2007 Jun 10; 56(3):363-9. PubMed ID: 17306906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.